Pharmaceutical Excipients Market

Published Jul 21, 2025

Length 237 Pages

SKU # CMI20302689

Description

Pharmaceutical excipients refer to inert substances used as vehicles or additives in drug formulations and products. These are used to confer additional desired properties, aid in product identification, enhance stability, or improve product appearance. Some common excipients include binders, coatings, disintegrants, flavoring agents, lubricants, preservatives, and sweeteners. Global pharmaceutical excipients market growth is driven by factors such as rising generic drug production, growth in oral solid dosage forms, and increasing regulatory considerations for excipient selection and characterization in drug development and manufacturing.

Market Dynamics

Global pharmaceutical excipients market growth is driven by factors such as rising generic drug production, growth in oral solid dosage forms, increasing regulatory considerations for excipient selection and characterization, and expansion of contract manufacturing and packaging facilities. Rising prevalence of chronic diseases worldwide which necessitates effective long-term drug therapies also boosts demand for pharmaceutical excipients. However, stringent regulatory policies mandating safety and quality evaluation of excipients can hamper the market growth. Technological advancements in novel drug delivery systems, demand for multifunctional excipients, and development of biopharmaceutical excipients can offer market growth opportunities.

Key Features of the Study

This report provides in-depth analysis of the global pharmaceutical excipients market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2025–2032), considering 2024 as the base year.
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global pharmaceutical excipients market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study include Dow, Ashland, BASF, Roquette, FMC, Evonik, Lubrizol, Associated British Foods, and Croda International.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
Global pharmaceutical excipients market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global pharmaceutical excipients market.

Market Segmentation

Product Type Insights (Revenue, USD Bn, 2025 - 2032)
Inorganic Chemicals
Organic Chemicals
Other Products
Functionality Insights (Revenue, USD Bn, 2025 - 2032)
Fillers and Diluents
Binders
Suspension
Viscosity Agents
Coatings
Flavoring Agents
Disintegrants
Colorants
Preservatives
Others
Formulation Insights (Revenue, USD Bn, 2025 - 2032)
Oral
Parenteral
Others
Regional Insights (Revenue, USD Bn, 2025 - 2032)
North America
U.S.
Canada
Latin America
Brazil
Argentina
Mexico
Rest of Latin America
Europe
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
Asia Pacific
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
GCC Countries
Israel
Rest of Middle East
Africa
South Africa
North Africa
Central Africa
Key Players Insights
Ashland Global Holdings Inc.
BASF SE
Innophos
DuPont de Nemours, Inc
Roquette Frères
Evonik Industries AG
Merck KGaA
JRS Pharma
Croda International Plc
Colorcon Inc.
Archer Daniels Midland Company (ADM)
The Lubrizol Corporation
Innophos Holdings Inc.
Kerry Group plc
WACKER Chemie AG
Meggle Group
DFE Pharma

1. Research Objectives and Assumptions: Research Objectives; Assumptions; Abbreviations
2. Market Purview: Report Description; Market Definition and Scope; Executive Summary; Market Snapshot, By Product Type; Market Snapshot, By Functionality; Market Snapshot, By Formulation; Market Snapshot, By Region; Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis: Market Dynamics; Drivers; Restraints; Opportunities; Impact Analysis; Market Trends; Key Developments; Regulatory Scenario; Acquisitions and Partnerships Scenario; Funding and Investments; PEST Analysis; Porter’s Analysis
4. Global Pharmaceutical Excipients Market, By Product Type, 2020 – 2032, (USD Bn): Overview; Market Share Analysis, 2025 and 2032 (%); Y-o-Y Growth Analysis, 2020 – 2032; Segment Trends; Inorganic Chemicals; Overview; Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn); Organic Chemicals; Overview; Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn); Others; Overview; Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn)
5. Global Pharmaceutical Excipients Market, By Functionality, 2020 – 2032, (USD Bn): Overview; Market Share Analysis, 2025 and 2032 (%); Y-o-Y Growth Analysis, 2020 – 2032; Segment Trends; Fillers and Diluents; Overview; Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn); Binders; Overview; Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn); Suspension; Overview; Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn); Viscosity Agents; Overview; Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn); Coatings; Overview; Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn); Flavoring Agents; Overview; Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn); Disintegrants; Overview; Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn); Colorants; Overview; Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn); Preservatives; Overview; Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn); Others; Overview; Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn)
6. Global Pharmaceutical Excipients Market, By Formulation, 2020 – 2032, (USD Bn): Overview; Market Share Analysis, 2025 and 2032 (%); Y-o-Y Growth Analysis, 2020 – 2032; Segment Trends; Oral; Overview; Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn); Parenteral; Overview; Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn); Others; Overview; Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Bn)
7. Global Pharmaceutical Excipients Market, By Region, 2020 – 2032, (USD Bn): Introduction; Market Share Analysis, By Region, 2025 and 2032 (%); Y-o-Y Growth Analysis, For Region, 2020–2032; Regional Trends; North America; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn); Market Size and Forecast, and Y-o-Y Growth, By Functionality, 2020 - 2032, (USD Bn); Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2020 - 2032, (USD Bn); Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 – 2032, (USD Bn); U.S.; Canada; Latin America; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn); Market Size and Forecast, and Y-o-Y Growth, By Functionality, 2020 - 2032, (USD Bn); Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2020 - 2032, (USD Bn); Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 – 2032, (USD Bn); Brazil; Mexico; Argentina; Rest of Latin America; Europe; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn); Market Size and Forecast, and Y-o-Y Growth, By Functionality, 2020 - 2032, (USD Bn); Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2020 - 2032, (USD Bn); Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 – 2032, (USD Bn); U.K.; Germany; Italy; France; Spain; Russia; Rest of Europe; Asia Pacific; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn); Market Size and Forecast, and Y-o-Y Growth, By Functionality, 2020 - 2032, (USD Bn); Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2020 - 2032, (USD Bn); Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 – 2032, (USD Bn); China; India; Japan; ASEAN; Australia; South Korea; Rest of Asia Pacific; Middle East; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn); Market Size and Forecast, and Y-o-Y Growth, By Functionality, 2020 - 2032, (USD Bn); Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2020 - 2032, (USD Bn); Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 – 2032, (USD Bn); GCC Countries; Israel; Rest of Middle East; Africa; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn); Market Size and Forecast, and Y-o-Y Growth, By Functionality, 2020 - 2032, (USD Bn); Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2020 - 2032, (USD Bn); Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 – 2032, (USD Bn); North Africa; Central Africa; South Africa
8. Competitive Landscape: Company Profiles; Ashland Global Holdings Inc.; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Market Strategies; BASF SE; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Market Strategies; Innophos; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Market Strategies; DuPont de Nemours, Inc.; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Market Strategies; Roquette Frères; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Market Strategies; Evonik Industries AG; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Market Strategies; Merck KGaA; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Market Strategies; JRS Pharma; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Market Strategies; Croda International Plc; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Market Strategies; Colorcon Inc.; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Market Strategies; Archer Daniels Midland Company (ADM); Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Market Strategies; The Lubrizol Corporation; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Market Strategies; Innophos Holdings Inc.; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Market Strategies; Kerry Group plc; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Market Strategies; WACKER Chemie AG; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Market Strategies; Meggle Group; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Market Strategies; DFE Pharma; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Market Strategies
9. Analyst Recommendations: Wheel of Fortune; Analyst View; Coherent Opportunity Map
10. References and Research Methodology: References; Research Methodology; About us and Sales Contact

Pricing

Currency Rates

Single User Email from Publisher $4,500
Site License Fulfilled by Publisher $7,000
Global Site License Email from Publisher $10,000

How Do Licenses Work?

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.

Chat Now